
### [MONDO:0016915](http://purl.obolibrary.org/obo/MONDO_0016915)
**Label:** partial deletion of the long arm of chromosome 17

**Subclasses:** [MONDO:0013357](http://purl.obolibrary.org/obo/MONDO_0013357) (chromosome 17q11.2 deletion syndrome, 1.4Mb), 

**Corr. equiv. classes:** [Orphanet:636](http://www.orpha.net/ORDO/Orphanet_636), [Orphanet:97685](http://www.orpha.net/ORDO/Orphanet_97685), [Orphanet:139474](http://www.orpha.net/ORDO/Orphanet_139474), [OMIM:613675](http://purl.obolibrary.org/obo/OMIM_613675), 

**Class expressions from DL-Learner:**

- [HP:0009732](http://purl.obolibrary.org/obo/HP_0009732) (Plexiform neurofibroma) and [HP:0200013](http://purl.obolibrary.org/obo/HP_0200013) (Neoplasm of fatty tissue) 62.50%
- [HP:0009732](http://purl.obolibrary.org/obo/HP_0009732) (Plexiform neurofibroma) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 62.50%
- [HP:0009732](http://purl.obolibrary.org/obo/HP_0009732) (Plexiform neurofibroma) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 62.50%
- [HP:0009732](http://purl.obolibrary.org/obo/HP_0009732) (Plexiform neurofibroma) and [HP:0100000](http://purl.obolibrary.org/obo/HP_0100000) (Early onset of sexual maturation) 62.50%
- [HP:0009732](http://purl.obolibrary.org/obo/HP_0009732) (Plexiform neurofibroma) and [HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa) 62.50%
- [HP:0009732](http://purl.obolibrary.org/obo/HP_0009732) (Plexiform neurofibroma) and [HP:0030453](http://purl.obolibrary.org/obo/HP_0030453) (Abnormal visual electrophysiology) 62.50%
- [HP:0009732](http://purl.obolibrary.org/obo/HP_0009732) (Plexiform neurofibroma) and [HP:0012733](http://purl.obolibrary.org/obo/HP_0012733) (Macule) 62.50%
- [HP:0009732](http://purl.obolibrary.org/obo/HP_0009732) (Plexiform neurofibroma) and [HP:0012243](http://purl.obolibrary.org/obo/HP_0012243) (Abnormal reproductive system morphology) 62.50%
- [HP:0009732](http://purl.obolibrary.org/obo/HP_0009732) (Plexiform neurofibroma) and [HP:0012031](http://purl.obolibrary.org/obo/HP_0012031) (Lipomatous tumor) 62.50%
- [HP:0009732](http://purl.obolibrary.org/obo/HP_0009732) (Plexiform neurofibroma) and [HP:0011843](http://purl.obolibrary.org/obo/HP_0011843) (Abnormality of skeletal physiology) 62.50%
- [HP:0009732](http://purl.obolibrary.org/obo/HP_0009732) (Plexiform neurofibroma) and [HP:0011729](http://purl.obolibrary.org/obo/HP_0011729) (Abnormality of joint mobility) 62.50%
- [HP:0009732](http://purl.obolibrary.org/obo/HP_0009732) (Plexiform neurofibroma) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) 62.50%
- [HP:0009732](http://purl.obolibrary.org/obo/HP_0009732) (Plexiform neurofibroma) and [HP:0011443](http://purl.obolibrary.org/obo/HP_0011443) (Abnormality of coordination) 62.50%
- [HP:0009732](http://purl.obolibrary.org/obo/HP_0009732) (Plexiform neurofibroma) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 62.50%
- [HP:0009732](http://purl.obolibrary.org/obo/HP_0009732) (Plexiform neurofibroma) and [HP:0011362](http://purl.obolibrary.org/obo/HP_0011362) (Abnormal hair quantity) 62.50%


